Why a forward-thinking approach is crucial for patient safety and industry success

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

A Pistoia Alliance survey looks at stakeholder concerns in AI regulations, and calls for more harmonization and collaboration.

How next-generation drug delivery and advanced automation are set to transform pharma’s future.

How will digitalization and automation redefine pharma manufacturing in the next decade?

Welcome to the labs of the future, with increased efficiency with robotics and automation, and new insights powered by AI and machine learning.

Takeda experts explore the potential of AI-driven drug discovery and the importance of including diverse patient voices in trial design.

Now, it’s time to start the integration process. Here are some top tips and points to consider.

How to meet the demand for first-in-human clinical trials using fit-for-phase formulation approaches.

Colleen Dixon and Mary Glotzbach discuss key areas for improvement, including automation, eco-friendly practices, and patient-centric delivery methods